Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly K Lee

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Immunity|August 17, 2022
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.
Cell Reports|August 24, 2017
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by HyperstabilizationAlba Torrents de la Peña, Jean-Philippe Julien, Steven W de Taeye, et al.
Cell|December 22, 2015
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesSteven W de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersRogier W Sanders, Marit J van Gils, Ronald Derking, et al.
Nature Structural & Molecular Biology|December 23, 2015
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine designJason Gorman, Cinque Soto, Max M Yang, et al.
The Journal of Experimental Medicine|May 10, 2018
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responsesNorbert Pardi, Michael J Hogan, Martin S Naradikian, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|November 8, 2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Immunity|August 17, 2022
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.
Cell Reports|August 24, 2017
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by HyperstabilizationAlba Torrents de la Peña, Jean-Philippe Julien, Steven W de Taeye, et al.
Cell|December 22, 2015
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesSteven W de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersRogier W Sanders, Marit J van Gils, Ronald Derking, et al.
Nature Structural & Molecular Biology|December 23, 2015
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine designJason Gorman, Cinque Soto, Max M Yang, et al.
The Journal of Experimental Medicine|May 10, 2018
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responsesNorbert Pardi, Michael J Hogan, Martin S Naradikian, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|November 8, 2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Pageof 10